The PFO closure device market is driven by a shift to minimally invasive solutions and patient-centric care. Opportunities lie in transcatheter methods, bioresorbable materials, regional reimbursement ...
While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...
Current age-based restrictions on patent foramen ovale (PFO) closure should be reconsidered in light of observational data suggesting that carefully selected older patients fare as well as those who ...
The study enrolled a group of 22 patients with symptomatic drug-refractory paroxysmal or short-time persistent AF and PFO who ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global structural heart disease treatment devices market since 2018 and the market is poised to grow by USD 5.61 billion during 2020-2024 at ...
We postulated that cryoablation can also fuse PFO by injuring the primary and secondary septum." Although AF and PFO are both risk factors for stroke/TIA, it is difficult to determine whether PFO is ...
An association between stress and cryptogenic ischemic stroke was observed in young women, but not young men, in a case-control study. (Neurology) Pooled cohort data suggested a likely causal ...
New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback